Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex

被引:61
作者
Herry, Isabelle
Neukirch, Catherine
Debray, Marie-Pierre
Mignon, Francoise
Crestani, Bruno
机构
[1] Hop Bichat Claude Bernard, AP HP, Serv Pneumol, F-75877 Paris 18, France
[2] Univ Paris 07, F-75221 Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Serv Radiol, F-75877 Paris 18, France
[4] Hop Bichat Claude Bernard, AP HP, Serv Nephrol, F-75877 Paris 18, France
关键词
angiomyolipomas; tuberous sclerosis complex; lymphangioleiomyomatosis; sirolimus;
D O I
10.1016/j.ejim.2006.07.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Angiomyolipomas are very common in patients with tuberous sclerosis complex (TSC) and cause substantial morbidity. Until now, arterial embolization has been the recommended treatment for symptomatic patients. We report the case of a woman with TSC and giant angiolipomas in whom sirolimus induced a dramatic reduction in bilateral renal tumors. (C) 2006 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:76 / 77
页数:2
相关论文
共 6 条
[1]   PULMONARY TUBEROUS SCLEROSIS [J].
CASTRO, M ;
SHEPHERD, CW ;
GOMEZ, MR ;
LIE, JT ;
RYU, JH .
CHEST, 1995, 107 (01) :189-195
[2]   Perturbed IFN-γ-jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models:: Synergistic effects of rapamycin-IFN-γ treatment [J].
El-Hashemite, N ;
Zhang, HB ;
Walker, V ;
Hoffmeister, KM ;
Kwiatkowski, DJ .
CANCER RESEARCH, 2004, 64 (10) :3436-3443
[3]   Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma [J].
El-Hashemite, N ;
Zhang, HB ;
Henske, EP ;
Kwiatkowski, DJ .
LANCET, 2003, 361 (9366) :1348-1349
[4]   Management of renal angiomyolipomas associated with tuberous sclerosis complex [J].
Harabayashi, T ;
Shinohara, N ;
Katano, H ;
Nonomura, K ;
Shimizu, T ;
Koyanagi, T .
JOURNAL OF UROLOGY, 2004, 171 (01) :102-105
[5]   Efficacy of a rapamycin analog (CCI-779) and IFN-γ in tuberous sclerosis mouse models [J].
Lee, L ;
Sudentas, P ;
Donohue, B ;
Asrican, K ;
Worku, A ;
Walker, V ;
Sun, YP ;
Schmidt, K ;
Albert, MS ;
El-Hashemite, N ;
Lader, AS ;
Onda, H ;
Zhang, HB ;
Kwiatkowski, DJ ;
Dabora, SL .
GENES CHROMOSOMES & CANCER, 2005, 42 (03) :213-227
[6]   Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex [J].
Moss, J ;
Avila, NA ;
Barnes, PM ;
Litzenberger, RA ;
Bechtle, J ;
Brooks, PG ;
Hedin, CJ ;
Hunsberger, S ;
Kristof, AS .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 164 (04) :669-671